These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13450738)

  • 1. A contribution to the study of collagen disease and the L.E. phenomenon.
    SHIPTON EA
    Med J Aust; 1957 Jun; 44(26):911-5. PubMed ID: 13450738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects of collagen diseases. II. Serological study on collagen diseases, with special reference to disseminated lupus erythematosus].
    KOMIYA M
    Jpn J Med Sci Biol; 1961 Nov; 50():720-30. PubMed ID: 14458125
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired circulating anticoagulants in systemic collagen disease; auto-immune thromboplastin deficiency.
    FRICK PG
    Blood; 1955 Jul; 10(7):691-706. PubMed ID: 14389382
    [No Abstract]   [Full Text] [Related]  

  • 4. Variations in the morphological patterns of "autoimmune" nuclear fluorescence.
    BECK JS
    Lancet; 1961 Jun; 1(7188):1203-5. PubMed ID: 13688397
    [No Abstract]   [Full Text] [Related]  

  • 5. [Titers of C 3 factor of serum complement in various autoimmune diseases].
    Lehman C; Andreis M; Bennett L; Godoy G
    Rev Med Chil; 1972; 100(5):497-501. PubMed ID: 4625016
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunofluorescent detection of antinuclear factor using washed, pooled peripheral human leukocytes.
    Gibson DC; Quarles JM
    Am J Clin Pathol; 1969 Apr; 51(4):440-4. PubMed ID: 4886839
    [No Abstract]   [Full Text] [Related]  

  • 7. Topics in clinical medicine. Complement levels in disease.
    Townes AS
    Johns Hopkins Med J; 1967 May; 120(5):337-43. PubMed ID: 6024563
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute disseminated lupus erythematosus; clinical picture and nosographic considerations, collagen diseases, lupus erythematosus cells, lupus erythematosus phenomenon, Haserick's globulin].
    MAZZEI ES; DAMENO E
    Prensa Med Argent; 1952 Aug; 39(32):1850-6. PubMed ID: 14957763
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recurrent spontaneous abortions associated with lupus anticoagulant in patients with collagen-vascular diseases].
    Ichikawa Y; Takaya M; Nozaki H; Kawada T; Uchiyama M; Shimizu H; Yamauchi K; Moriuchi J; Arimori S
    Ryumachi; 1985 Apr; 25(2):87-94. PubMed ID: 3929398
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrin fibrinogen degradation products in the blood in systemic lupus erythematosus and other major collagen diseases].
    Wysocka K; Kiczak J
    Reumatologia; 1982; 20(1-2):15-21. PubMed ID: 7163659
    [No Abstract]   [Full Text] [Related]  

  • 11. THE COLLAGENOSES: TRANSITIONAL FORMS OF LUPUS ERYTHEMATOSUS, DERMATOMYOSITIS, AND SCLERODERMA.
    KIERLAND RR
    Mayo Clin Proc; 1964 Jan; 39():53-9. PubMed ID: 14105415
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immuno-biological studies of collagen diseases with special reference to erythematodes. II. Presence in the blood of the so-called erythrocyte aggregation factor].
    RASPONI L
    Arch Ital Dermatol Sifilogr Venereol; 1957; 29(1):54-67. PubMed ID: 13498974
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lupus anticoagulant: an increasingly used marker].
    Castañeda Sanz S; Herrero-Beaumont G; Tornero Molina J; Aguado García JM; Outeiriño J
    Rev Clin Esp; 1985 Jun; 177(1):1-6. PubMed ID: 3929341
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood DNA- and RNA-binding activity in systemic lupus erythematosus and other collagenoses in children].
    Kvachadze IM; Adamashvili IM; Makarova OV; Sheliia NV
    Pediatriia; 1980; (9):30-2. PubMed ID: 6159570
    [No Abstract]   [Full Text] [Related]  

  • 15. [PATHOLOGICAL OBSERVATION ON ERYTHEMATOSUS].
    FUJIMAKI S
    Arerugi; 1964 May; 13():320-8. PubMed ID: 14148060
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant erythematodes (acute lupus erythematosus disseminatus); clinical picture and nosographic revaluation; collagen diseases; lupus erythematosus cells; lupus erythematosus phenomenon; Haserick's globulin].
    MAZZEI ES; DAMENO E
    Rev Clin Esp; 1952 Dec; 47(5):309-14. PubMed ID: 13056249
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal structures in circulating lymphocytes from patients with systemic lupus erythematosus and related diseases.
    Grrimley PM; Decker JL; Michelitch HJ; Frantz MM
    Arthritis Rheum; 1973; 16(3):313-23. PubMed ID: 4708012
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenic role of intravascular coagulation in immune diseases.
    Papilian M; Purice S; Niţă I; Tanaăseanu S
    Med Interne; 1977; 15(4):341-7. PubMed ID: 594617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution to the study of blood coagulation changes in some collagen diseases].
    GARBIN S; GAROFALO E
    Riv Anat Patol Oncol; 1959 Mar; 15():xxxiv-xxxix. PubMed ID: 13826381
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autoimmunity phenomena in systemic lupus erythematosus and in other diffuse reactive mesenchymopathies].
    Masala C; Pala AM; De Philippis CV
    Folia Allergol (Roma); 1967; 14(6):607-14. PubMed ID: 5583592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.